Antibodies that bind to EphA2 and methods of use thereof

Details for Australian Patent Application No. 2006210460 (hide)

Owner MacroGenics West, Inc.

Inventors Mather, Jennie P.; Roberts, Penelope E.

Agent Fisher Adams Kelly

Pub. Number AU-B-2006210460

PCT Pub. Number WO2006/084226

Priority 60/650,047 04.02.05 US

Filing date 6 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 5 April 2012

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

C12N 5/16 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/084226 Priority application(s): WO2006/084226

17 January 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Nov 2007

17 April 2008 Section 223 Application Received

  Raven biotechnologies, inc. An application to extend the time from 09 Aug 2006 to 09 Jan 2008 in which to comply with Section 6(c) has been filed . Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

5 June 2008 Section 223 Application Allowed

  Raven Biotechnologies, Inc. The time in which to comply with Section 6(c) has been extended to 09 Jan 2008. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

15 October 2009 Amendment Made

  The nature of the amendment is: Amend applicant name from Raven Biotechnologies, Inc. to Raven biotechnologies, inc.

25 November 2010 Alteration of Name

  The name of the applicant has been altered to MacroGenics West, Inc.

5 April 2012 Application Accepted

  Published as AU-B-2006210460

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210461-Travel multiplier mechanisms for writing instruments

2006210451-RNAi-mediated inhibition of ocular hypertension targets